Expert lecture examines DUSP10 as a regulatory node in antitumor immunity and colorectal cancer models

An expert lecture from ImmuneZoom covered the dual-specificity phosphatase (DSP/DUSP) family's role in regulating inflammation, infection, metabolism and cancer, focusing on DUSP10's control of type I interferon and inflammatory cytokines (IL-6, TNF-alpha) through TBK1. In an AOM-DSS colon cancer model, DUSP10 knockout mice developed more and larger colon tumors, with bone marrow transplants indicating an immune-system-driven rather than tumor-cell-autonomous phenotype. DUSP10 also affects activation, proliferation and differentiation of naive CD4 and CD8 T cells, marking it as a potential modifiable node for tumor immunotherapy, though mechanisms and clinical translation await publication and independent validation.